30 unknown. 30 Phase 2, 7 Phase 3, 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 30 | Unknown 30 |
| Phase 3 | 7 | Unknown 7 |
| Phase 1 | 6 | Unknown 6 |
Follow Mycoses: new trials by email Literature Review of Mycoses trials Research Report on Mycoses
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CelAgace™ OraRinse Solution for Treatment of Candidiasis silver citrate complex and acemannan - Candidiasis, Oral | Phase 1 / Phase 2 | Unknown | CelaCare Technologies, Inc. | 15 | 2024-09-01 | 2024-02-09 |
| Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection BGY-1601-VT, PLACEBO - Bacterial Vaginosis, Vulvovaginal Candidiasis | Phase 1 / Phase 2 | Unknown | NEXBIOME THERAPEUTICS | 165 | 2024-07-08 | 2024-06-12 |
| Study to Assess the Safety and Efficacy of Intravenous BSG005 in Patients With Invasive Fungal Infection BSG005 - Invasive Fungal Infection | Phase 1 / Phase 2 | Unknown | Biosergen AS | 15 | 2024-07-01 | 2025-04-06 |
| Efficacy and Safety of Terbinafine and Itraconazole Terbinafine Tablets, Itraconazole - Tinea Corporis, Tinea Cruris | Phase 2 / Phase 3 | Unknown | Dhaka Medical College | 150 | 2023-05-01 | 2023-05-31 |
| A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis DBI-001 Gel, DBI-002 Gel, Aqueous Gel - Tinea Pedis | Phase 2 | Unknown | DermBiont, Inc. | 24 | 2022-09-08 | 2023-02-14 |
| A Clinical Trial for Chlorhexidine as Treatment for Vulvovaginal Candidiasis Chlorhexidine Gluconate, Fluconazole - Candidiasis, Vulvovaginal | Phase 2 | Unknown | Karolinska Institutet | 60 | 2022-04-27 | 2022-05-20 |
| To Evaluate Hallux Terbinafine Subungual Gel (HSG) in the Treatment of Onychomycosis Hallux Terbinafine Subungual Gel - Onychomycosis of Toenail | Phase 2 | Unknown | Hallux, Inc. | 35 | 2022-01-13 | 2023-08-07 |
| A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection Posaconazole 100 MG [Noxafil], Posaconazole 40 MG/ML - Cystic Fibrosis, Aspergillosis | Phase 2 / Phase 3 | Unknown | Bambino Gesù Hospital and Research Institute | 135 | 2021-04-22 | 2021-07-19 |
| Systemic Uptake of Diclofenac Sodium in Combination With Miconazole as Antifungal Nail Gel When Applied Daily With Monitoring of Hepatic and Renal Enzymes, and Serum Levels of Diclofenac 12 Hours After Application, and at 3 and 6 Months Study Antifungal Nail Gel Study - Tinea Unguium, Onychomycosis | Phase 2 | Unknown | William N Handelman | 30 | 2020-05-01 | 2020-04-10 |
| Escalation Antifungal Prophylaxis for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Escalating prophylaxis - Fungal Infection | Phase 2 | Unknown | Shanghai Jiao Tong University School of Medicine | 175 | 2020-01-15 | 2021-11-26 |
| Amphotericin B Cholesteryl Sulfate Complex for Injection(ABCD) in the Treatment of Invasive Candidiasis and Invasive Aspergillosis Amphotericin B cholesteryl sulfate complex for injection(ABCD) - Invasive Candidiasis, Invasive Aspergillosis | Phase 2 | Unknown | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 60 | 2020-01-01 | 2020-01-13 |
| A Phase IIb/III Study of Prof-001 for the Treatment of Patients With Recurrent Vulvovaginal Candidiasis (RVVC) Prof-001, Fluconazole 150 mg, Placebo cream - Recurrent Vulvovaginal Candidiasis | Phase 2 / Phase 3 | Unknown | ProFem GmbH | 432 | 2019-10-01 | 2022-09-22 |
| SINGLE-APPLICATION TERBINAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION VERSUS A SINGLE-APPLICATION BUTENAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION FOR THE TREATMENT OF TINEA PEDIS TERBINAFINE HYDROCHLORIDE (1%), BUTENAFINE HYDROCHLORIDE (1%), Vehicle Control - Tinea Pedis | Phase 2 | Unknown | United Laboratories | 42 | 2019-01-02 | 2019-06-26 |
| Universal Prophylaxis Versus Pre-emptive Therapy With Posaconazole Post-Lung Transplant Universal Posaconazole Prophylaxis, Pre-emptive Posaconazole Therapy - Fungal Infection | Phase 2 | Unknown | Bayside Health | 140 | 2018-07-02 | 2018-06-19 |
| Isotretinoin In Preventing Recurrences In Chronic Recurrent Dermatophytosis Isotretinoin, Terbinafine, Itraconazole 200 mg - Tinea | Phase 2 | Unknown | Post Graduate Institute of Medical Education and Research, Chandigarh | 100 | 2018-04-01 | 2018-05-01 |
| Patients With Vulvovaginal Candidiasis EPP-AF Gel 1%, EPP-AF Gel 2%, Clotrimazole - Vulvovaginal Candidiasis | Phase 1 / Phase 2 | Unknown | University of Sao Paulo | 90 | 2018-01-30 | 2018-10-19 |
| Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis Group 1 Natamycin 5% Suspension + voriconazole 1% eye drops; Group 2 Natamycin 5% Suspension + Vehicle eye drops - Infection, Fungal | Phase 2 / Phase 3 | Unknown | L.V. Prasad Eye Institute | 55 | 2017-01-01 | 2017-07-26 |
| The Efficacy of CELEXT07 in the Treatment of Toenail Onychomycosis CELEXT07, Penlac, vehicle solution - Onychomycosis | Phase 2 | Unknown | 9305-9954 Quebec Inc | 120 | 2016-11-01 | 2017-04-26 |
| Treatment for Presumed Ocular Histoplasmosis aflibercept - Ocular Histoplasmosis | Phase 1 / Phase 2 | Unknown | John Kitchens, MD | 40 | 2013-03-01 | 2014-06-16 |
| Study of Trimethoprim/Sulfamethoxazole as PCP Prophylaxis in CTD Patients Trimethoprim/Sulfamethoxazole - Pneumonia, Pneumocystis, Prevention & Control | Phase 2 / Phase 3 | Unknown | Peking Union Medical College Hospital | 80 | 2012-08-01 | 2012-12-11 |
Showing 20 of 30. Sign in to see all of them.
Onychomycosis (6) · Candidiasis, Vulvovaginal (4) · Invasive Fungal Infections (4) · Histoplasmosis (3) · Tinea (2) · Tinea Pedis (2) · Aspergillosis (1) · Candidiasis, Invasive (1) · Candidiasis, Oral (1) · Cystic Fibrosis (1) · Fungemia (1) · HIV Infections (1) · Leukemia, Myeloid, Acute (1) · Meningitis, Cryptococcal (1)
Bacterial Infections and Mycoses (30) · Infections (30) · Dermatomycoses (10) · Skin Diseases (10) · Skin Diseases, Infectious (10) · Skin and Connective Tissue Diseases (10) · Tinea (8) · Candidiasis (6) · Nail Diseases (6) · Genital Diseases (5) · Urogenital Diseases (5) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Genital Diseases, Female (4)
Fluconazole (3) · Terbinafine (3) · Caspofungin (2) · Itraconazole (2) · Ranibizumab (2) · Suspensions (2) · Amphotericin B (1) · BANG polymer gel (1) · Ciclopirox (1) · Clotrimazole (1) · Diclofenac (1) · Flucytosine (1) · Isotretinoin (1) · Lasers, Solid-State (1) · Micafungin (1)
Bayside Health (2) · Nomir Medical Technologies (2) · 9305-9954 Quebec Inc (1) · ANRS, Emerging Infectious Diseases (1) · Azienda Ospedaliera di Padova (1) · Bambino Gesù Hospital and Research Institute (1) · Barnes Retina Institute (1) · Biosergen AS (1) · Brasilia University Hospital (1) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1) · CelaCare Technologies, Inc. (1) · DermBiont, Inc. (1) · Dhaka Medical College (1) · Grupo de Estudio de Infecciones en Transplantados (1) · Hallux, Inc. (1)
United States (9) · Australia (2) · Brazil (2) · China (2) · India (2) · Italy (2) · Spain (2) · Austria (1) · Burundi (1) · Canada (1) · Czechia (1) · Côte d’Ivoire (1) · France (1) · Germany (1) · Greece (1)
Adilia Warris, Prof (1) · Alan Robbins, M.D. (1) · Anthony P Schwarer, MB, BS, FRACP, MD, FRCPA (1) · C. Orla Morrissey, MB, BCh, FRACP (1) · Cathrin Alvendal, MD, PhD (1) · Daniel P. Mallett, DPM (1) · Daniele Neri, MD (1) · Emma Taylor, Ph.D (1) · Fengchun Zhang, MD (1) · Guy Chamberland, M.Sc., Ph.D. (1) · Herbert Kiss, Prof. (1) · Hyoung Jin Kang, M.D, Ph.D (1) · Jacqueline M. Plemons, DDS, MS (1)
PMID 15232472, PMID 23410808, PMID 24173203, PMID 27297276, PMID 41365527, PMID 41845293
2008 (1), 2019 (1)